Artificial Intelligence and Biosecurity Risk Assessment Act

Bill: 118-s-2399
Sponsor: full_name: Sen. Markey, Edward J. [D-MA]
Introduced: 2023-07-19
Policy area: Health
Subjects: Advanced technology and technological innovations

Chemical and biological weapons

Infectious and parasitic diseases

Technology assessment
Latest action: action_date: 2023-07-19
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2023-07-19
action_desc: Introduced in Senate
text: <p><strong>Artificial Intelligence and Biosecurity Risk Assessment Act</strong></p><p>This bill requires the Administration for Strategic Preparedness and Response to assess the risks posed by artificial intelligence in developing novel pathogens, viruses, bioweapons, or chemical weapons and to address these risks through related initiatives and activities, such as by including the risk assessment in the National Health Security Strategy (a coordinated strategy among federal, state, and local entities to address public health emergencies).</p>

tv_txt: II 118th CONGRESS 1st Session S. 2399 IN THE SENATE OF THE UNITED STATES July 19, 2023 Mr. Markey (for himself and Mr. Budd ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To require the Assistant Secretary for Preparedness and Response to conduct risk assessments and implement strategic initiatives or activities to address threats to public health and national security due to technical advancements in artificial intelligence or other emerging technology fields.

1. Short title This Act may be cited as the Artificial Intelligence and Biosecurity Risk Assessment Act . 2. Assessment of emerging risks of artificial intelligence Section 2811 of the Public Health Service Act ( 42 U.S.C. 300hh–10 ) is amended by adding at the end the following: (h) Assessment of emerging risks In carrying out subsection (b)(4)(I), the Assistant Secretary for Preparedness and Response shall conduct risk assessments and implement strategic initiatives or activities to address whether technical advancements in artificial intelligence, such as open-source artificial intelligence models and large language models, can be used intentionally or unintentionally to develop novel pathogens, viruses, bioweapons, or chemical weapons. Such initiatives and activities may include— (1) regularly monitoring and researching potential global biological catastrophic risks in which biological agents could lead to sudden, extraordinary loss of life and sustained damage to national governments, international relationships, economies, societal stability, or global security; and (2) including in the National Health Security Strategy under section 2802 a summary of the risk assessment conducted under this subsection. .